CanadaPMS‑ZOLPIDEM ODT 10 mg (Zolpidem tartrate tablets), DIN 02436183, Lot 76270, marketed by Pharmascience Inc., may have missing tablets in blister packs and is being recalled. Check your product by matching the brand, product name, DIN and lot number to see if it is affected. Verify if your product is affected, consult your healthcare provider before stopping use or for health concerns, contact Pharmascience with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Pharmascience Inc., 6111 avenue Royalmount, suite 100,, Montréal, QC, H4P 2T4.
How to identify it
Brand: Pharmascience; Product Name: PMS-ZOLPIDEM ODT 10mg; Market Authorization: DIN 02436183; Dosage Form: Tablet; Strength: ZOLPIDEM TARTRATE 10mg; Lot number: 76270
The hazard
Affected lot may be missing tablets in blister packs
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)